MK-0557

Cat. No.: OB0225LY-0002

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: MK-0557 is a small molecule inhibitor targeting specific protein kinases.

Synonym: 328232-95-7; MK0557; MK 0557; MK 0557-Bio-X; Spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-H-pyrazol-3-yl)-1'-oxo-, trans-; (1S,4S)-N-(1-(2-Fluorophenyl)-1H-pyrazol-3-yl)-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxamide; N-[1-(2-Fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide; trans-N-(1-(2-Fluorophenyl)-3-pyrazolyl)-3-oxospiro(6-azaisobenzofuran-1(3H),1'-cyclohexane)-4'-carboxamide; (1R,4R)-N-[1-(2-Fluorophenyl)-1H-pyrazol-3-yl]-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxamide

CAS No.: 328232-95-7

Compound CID: 11491176

Formula: C₂₂H₁₉FN₄O₃

Formula Weight: 406.41

Specification

Relative Density: 1.46 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: MK-0557 can be used to inhibit the activity of protein kinases, thereby blocking downstream signaling pathways that promote cancer cell proliferation and survival.